RxBiologics Limited – Trademark Portfolio
Entity Type: 99
RxBiologics Limited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GALAXY.
The Dorothy Hodgkin Building,
Babraham Research Campus Babraham, CAMBR
Showing of trademarks Trademarks
Trademark Classifications
RxBiologics Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does RxBiologics Limited have?
RxBiologics Limited has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does RxBiologics Limited file in?
RxBiologics Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are RxBiologics Limited's most well-known trademarks?
RxBiologics Limited's registered trademark portfolio includes well-known marks such as GALAXY. These are among 1 currently registered trademark in the portfolio.
What is RxBiologics Limited's trademark registration success rate?
RxBiologics Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.